Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration

HitGen says the partnership could speed up the provision of innovative medicines

By: Betsy Louda

, Contract Pharma

HitGen has entered into a drug discovery research collaboration with Boehringer Ingelheim to identify novel small molecule leads for targets of interest. 

 

Under the agreement, HitGen will use its technology platform, based on DNA-encoded library design, synthesis, and screening, to discover the leads for Boehringer Ingelheim. HitGen will receive upfront payments, and will also be eligible for milestone payments from Boehringer Ingelheim. 

 

“This collaboration further emphasizes the role of HitGen in the rapidly developing field of DNA-encoded chemistry. We will work closely with Boehringer Ingelheim scientists to generate new lead compounds for their research programmes to address unmet medical needs.” said Dr. Jin Li, chairman and chief executive officer of HitGen.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics